Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial
Garcia del Muro, Xavier, Valderrama, Begoña P., Medina, Ana, Cuellar, M. Andres, Etxaniz, Olatz, Gironés Sarrió, Regina, Juan-Fita, María Jose, Ferrer, Ferran, Miras Rodríguez, Isabel, Lendínez-Cano, Guillermo, de Haro Piedra, Roberto, Candal Gomez, Arturo, Chantada Abal, Venancio, Buisán, Oscar, Villà, Salvador, Pontones, José Luis, Collado, Erica, Domínguez-Escrig, José L., Murria, Yashmina, Vigués, Francesc
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
The role of PCA3 testing in a homogenenous population of patients with low and intermediate-risk prostate cancer treated with brachytherapy
Medina, Ana, Losada, Raquel, Mariño, Alfonso, Candal Gómez, Arturo, Diaz, Inmaculada, Ramos Vazquez, Manuel, Fernandez, Jose Luis, Garcia, Sonia Aranzazu, Mendez, Carlos, Azpitarte, Cristina, Paris, Lorena, Chantada Abal, Venancio, Martinez Breijo, Sara, Antón Aparicio, Luis M., Olmos, David
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article